» Articles » PMID: 36853379

Long-term Supplementation with 3200 to 4000 IU of Vitamin D Daily and Adverse Events: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Overview
Journal Eur J Nutr
Date 2023 Feb 28
PMID 36853379
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The upper tolerable intake level for vitamin D in the general population has been set at 4000 international units (IU) daily, but considerable uncertainty remains. We summarized reported harmful effects of a daily vitamin D supplement of 3200-4000 IU in trials lasting ≥ 6 months.

Methods: We performed a systematic review and meta-analysis of randomized controlled trials in several databases and identified 22 trials reporting safety data. Parameters of calcium metabolism, falls, hospitalization, and mortality were assessed.

Results: The selected trials comprised a total number of 12,952 participants. All trials used supplemental vitamin D. The relative risk (RR) of hypercalcemia in the vitamin D vs. control arm was 2.21 (95%CI: 1.26-3.87; 10 studies), with a vitamin D-induced frequency of hypercalcemia of 4 cases per 1000 individuals. Subgroup analysis in trials with > 100 and ≤ 100 study participants revealed an RR of 2.63 (95%CI: 1.30-5.30; 7 studies) and 0.80 (95%CI: 0.24-2.62; 3 studies), respectively (P = 0.06). Risks of falls and hospitalization were also significantly increased in the vitamin D arm with an RR of 1.25 (95%CI: 1.01-1.55; 4 studies) and 1.16 (95%CI: 1.01-1.33; 7 studies), respectively. Risks of hypercalciuria, kidney stones, and mortality did not differ significantly between study arms. Quality assessment revealed high risk of incomplete reporting of safety-related outcome data.

Conclusion: Supplemental vitamin D doses of 3200-4000 IU/d appear to increase the risk of hypercalcemia and some other adverse events in a small proportion of individuals, indicating that this dose is not completely safe. In future studies, rigorous reporting of safety-related outcomes is needed when using moderately high doses of vitamin D.

Citing Articles

Vitamin D, C-Reactive Protein, and Increased Fall Risk: A Genetic Epidemiological Study.

Sutherland J, Zhou A, Hypponen E Nutrients. 2025; 17(1.

PMID: 39796472 PMC: 11722653. DOI: 10.3390/nu17010038.


Comparative Analyses of the Safety Profiles of Vitamin D Receptor Agonists: A Pharmacovigilance Study Based on the EudraVigilance Database.

Gall Z, Kolcsar M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770528 PMC: 11677518. DOI: 10.3390/ph17121686.


The effectiveness of vitamin D supplementation in patients with end-stage knee osteoarthritis: Study protocol for a double-blinded, randomized controlled trial.

Wang Q, Ong M, Man G, Yeung Y, He X, Choi B PLoS One. 2024; 19(10):e0309610.

PMID: 39432457 PMC: 11493297. DOI: 10.1371/journal.pone.0309610.


Targeting Calcitriol Metabolism in Acute Vitamin D Toxicity-A Comprehensive Review and Clinical Insight.

Aberger S, Schreiber N, Pilz S, Eller K, Rosenkranz A, Kirsch A Int J Mol Sci. 2024; 25(18).

PMID: 39337491 PMC: 11431961. DOI: 10.3390/ijms251810003.


Optimal methods of vitamin D supplementation to prevent acute respiratory infections: a systematic review, dose-response and pairwise meta-analysis of randomized controlled trials.

Wang C, Porta L, Yang T, Wang Y, Wu T, Qian F Nutr J. 2024; 23(1):92.

PMID: 39143549 PMC: 11323636. DOI: 10.1186/s12937-024-00990-w.


References
1.
Zittermann A, Prokop S, Gummert J, Borgermann J . Safety issues of vitamin D supplementation. Anticancer Agents Med Chem. 2012; 13(1):4-10. View

2.
Malihi Z, Wu Z, Lawes C, Scragg R . Adverse events from large dose vitamin D supplementation taken for one year or longer. J Steroid Biochem Mol Biol. 2018; 188:29-37. DOI: 10.1016/j.jsbmb.2018.12.002. View

3.
Bischoff-Ferrari H, Dawson-Hughes B, Orav E, Staehelin H, Meyer O, Theiler R . Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial. JAMA Intern Med. 2016; 176(2):175-83. DOI: 10.1001/jamainternmed.2015.7148. View

4.
Sanders K, Stuart A, Williamson E, Simpson J, Kotowicz M, Young D . Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010; 303(18):1815-22. DOI: 10.1001/jama.2010.594. View

5.
Ginde A, Blatchford P, Breese K, Zarrabi L, Linnebur S, Wallace J . High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial. J Am Geriatr Soc. 2016; 65(3):496-503. PMC: 5357189. DOI: 10.1111/jgs.14679. View